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ABSTRACT
PMD (Pelizaeus–Merzbacher disease), a CNS (central
nervous system) disease characterized by shortened life-
span and severe neural dysfunction, is caused by mutations
of the PLP1 (X-linked myelin proteolipid protein) gene. The
majority of human PLP1 mutations are caused by
duplications; almost all others are caused by missense
mutations. The cellular events leading to the phenotype are
unknown. The same mutations in non-humans make them
ideal models to study the mechanisms that cause
neurological sequelae. In the present study we show that
mice with Plp1 duplications (Plp1tg) have major mitochon-
drial deficits with a 50% reduction in ATP, a drastically
reduced mitochondrial membrane potential and increased
numbers of mitochondria. In contrast, the jp (jimpy) mouse
with a Plp1 missense mutation exhibits normal mitochon-
drial function. We show that PLP in the Plp1tg mice and in
Plp1-transfected cells is targeted to mitochondria. PLP has
motifs permissive for insertion into mitochondria and
deletions near its N-terminus prevent its co-localization to
mitochondria. These novel data show that Plp1 missense
mutations and duplications of the native Plp1 gene initiate
uniquely different cellular responses.
Key words: mitochondrion, oligodendrocyte, oxidative phos-
phorylation, Pelizaeus–Merzbacher disease, Plp1 mutant.
INTRODUCTION
PMD (Pelizaeus–Merzbacher disease) is caused by mutations
in the CNS (central nervous system) PLP1 (X-linked
proteolipid protein 1) gene (Hodes et al., 1993; Boespflug-
Tanguy et al., 1994; Ellis and Malcolm, 1994). PLP1 mutations
fall into four broad classes: (i) duplications of the native
(wild-type) gene, (ii) point mutations, (iii) deletions, and (iv)
frameshift mutations. Duplications account for nearly 70% of
human PLP1 mutations (Garbern et al., 1999; Garbern, 2007).
In many humans, the duplications are lethal, with death
ensuing within the first decade. No treatments are available
for PMD patients except for medications to counteract
seizures and spasticity. The sequence of cellular events that
cause neurological dysfunction and ultimately death is poorly
understood in PMD patients. Because Plp1 mutations in
animals are often identical with those in humans and both
present with similar motor deficits, they are useful models to
study PMD. An UPR (unfolded protein response) has been
demonstrated in rodents and in cell lines with missense muta-
tions (Southwood et al., 2002; McLaughlin et al., 2007) and in
cell lines that overexpress mutant Plp1 (Dhaunchak and Nave,
2007). Not surprisingly, trafficking of mutant PLP to the
plasma membrane is altered (Thomson et al., 1997). In animals
with missense mutations, this UPR and aberrant protein
trafficking is thought to cause Olg (oligodendrocyte)
malfunction. However, in rodents with duplications of the
Plp1 gene, investigation of cellular and molecular events is
limited. In mice with low Plp1 gene copy number, abnormal
accumulation of PLP in the ER (endoplasmic reticulum) and a
subsequent UPR is barely detectable (Cerghet et al., 2001).
Moreover, it is apparently lacking in Olgs transfected with
wild-type PLP (Kramer-Albers et al., 2006). We also observed
major differences in expression of apoptotic markers between
these two mutants. For example, we surprisingly found
that AIF (apoptosis-inducing factor) was translocated into
nuclei of Plp1tg (mice with Plp1 duplications) mice 4-fold
more than in jp (jimpy) mice (Supplementary Figure S1 at
http://www.asnneuro.org/an/001/an001e014.add.htm). We
predicted the reverse results because apoptosis is approx.
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Translocation of AIF to nuclei is significant in understanding
cell death pathways because this protein is highly up-
regulated in the caspase-independent or mitochondrially
dependent pathway (Cregan et al., 2004; Haeberlein, 2004).
Moreover, it is activated in response to PARP [poly(ADP-
ribose) polymerase] activation which we also found elevated
in the Plp1tg mice (Cerghet et al., 2001). These observations,
taken together, suggest that different cell death pathways
operate in the two major classes of Plp1 mutations. In the
present study, we examine mitochondrial function in the
two mutants and show, for the first time, that mice with
duplications of the Plp1 gene exhibit major mitochondrial
defects.
MATERIALS AND METHODS
Animals, phenotyping and genotyping
All animals were housed in the Division of Laboratory Animal
Resources, a federally approved animal facility, and all
procedures were approved by the Wayne State University
Animal Investigation Committee. Plp1/
jp jimpy/Tabby female
carriers (jp+/+Ta) and males (+Ta) were purchased from
Jackson Laboratories. Jp mice were genotyped by PCR. Tails
were cut from neonatal mice, DNA isolated and purified with
an Extract-N-Amp Tissue PCR Kit (Sigma), and PCR was
performed using the following primers, 59-CATGCCTCTAGC-
CTTATGAAGTTAC-39 and 59-CCTCAGCTGTTTTGCAGATGGA-
CAG-39, that amplifies a portion of intron 4 and exon 5
which includes a DdeI site. The DNA was digested with Dde1,
resolved on a 6% acrylamide gel and visualized with ethidium
bromide. The DdeI restriction site is lost in jp so amplified
DNA, when digested with DdeI, will yield one band at 125 bp
for jp males, two bands at 75 and 50 bp for wild-type males
and females, and all three bands for heterozygous females.
Plp1tg line 66 mice were obtained from Dr C. Readhead
(Cedars-Sinai Hospital, Los Angeles, CA, U.S.A.). The seven
exon transcription Plp1 mouse unit and 3.5 kb of the Plp1 59-
regulatory unit were used to generate line 66 transgenic mice
(Readhead et al., 1994). Most Plp1tg mice develop tremors
between 25–40 days after birth followed by seizures a few
days later. All mice used in the present study exhibited
tremors and/or seizures. In our initial studies, offspring from
Plp1tg carrier mice were identified following the procedure
of Readhead et al. (1994) for the presence or absence of the
T7 promoter sequence contained in the inserted vector. Tails
were cut from neonatal mice, DNA was isolated and purified
as described above and PCR was performed using the primers
59-CAGGTGTTGAGTCTGATCTACACAAG-39 and 59-
GCATAATACGACTCACTATAGGGATC-39. PCR products were
resolved on a 1.5% agarose gel, and visualized with ethidium
bromide. Transgenic mice have a 250 bp product. In later
studies, Plp1tg mice were genotyped using real-time PCR
(Regis et al., 2005). DNA was isolated from neonatal mice tails
and purified with the DNeasy Tissue Kit (Qiagen). The
oligonucleotide primers specific for exon 3 of the Plp1 gene
(59-GGGCTCCAGAACATCATCC-39 and 59-GTCCACCACTGACA-
CGTTGG-39) were used to amplify a 131 bp product. The Plp1
gene dosage was determined by the relative quantitative
comparative threshold cycle method (DDCt). Primers specific
for exon 7 of the GAPDH (glyceraldehyde-3-phosphate
dehydrogenase) gene served as an endogenous reference
gene. Amplification of GAPDH and Plp1 were run simulta-
neously in separate tubes. Males with more than two extra
copies and females with more than four extra copies usually
exhibited behavioural abnormalities.
ATP measurements
All mice were starved for 5–6 h, starting in the morning
(water was provided ad libitum). Mice were sacrificed by
cervical dislocation, brains immediately excised, frozen in
liquid nitrogen, and stored at 280˚C until measurement. In
order to release cellular ATP, frozen tissue (25 mg) was boiled
for 2 min after the addition of 300 ml of water containing
100 mM Tris/HCl (pH 7.75) and 4 mM EDTA. Samples were
placed on ice and homogenized by sonification (micro tip,
1610 s pulse). ATP concentrations were determined in
triplicate per animal using the ATP bioluminescence assay kit
HS II (Roche) according to the manufacturer’s protocol, using
an Optocomp 1 luminometer (MGM Instruments). Data were
standardized to the protein concentration which was
determined using the DC protein assay kit (Bio-Rad). Results
were expressed as the means¡S.E.M. for three independent
measurements per animal. The significance between multiple
groups was determined using ANOVA.
CcO (cytochrome c oxidase) brain measurements
CcO activity was determined as previously described (Lee
et al., 2005) with modifications. Brain plugs (25 mg) were
solubilized in 500 ml of chilled measuring buffer [10 mM
potassium Hepes (pH 7.4), 40 mM KCl, 1% Tween 20, 2 mM
oligomycin, 1 mM PMSF, 10 mM potassium fluoride, 1 mM
sodium vanadate and 2 mM EGTA] using a Teflon microtube
pestle applying five strokes followed by sonification (micro
tip, 3610 s pulses). Cell debris was removed by centrifu-
gation (2 min at 16000 g) and the supernatant was used for
respiration measurements. The protein concentration was
determined using the DC protein assay kit. CcO activity was
determined at 25˚C in a closed 200 ml chamber containing a
micro Clark-type oxygen electrode (Oxygraph system,
Hansatech Instruments) by increasing the amount of
substrate cytochrome c. Since CcO is regulated by adenine
nucleotides (Napiwotzki et al., 1997), measurements were
performed in the presence of 5 mM ADP or 5 mM ATP
including an ATP-regenerating system (Lee et al., 2002).
Oxygen consumption was recorded on a computer and
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(turnover number) is defined as consumed oxygen [mM/min
per mg of total protein].
CcO histochemistry
CcO activity was measured on 15 mm frozen brain sections at
the level of the striatum (Wong-Riley, 1979) with modifica-
tions (Hu ¨ttemann et al., 2008). Briefly, slides were transferred
from 280˚C to room temperature (20˚C) and tissue sections
were circled with a hydrophobic pen, allowing the application
of small reaction buffer volumes. Then, 100 ml of freshly
prepared reaction buffer [100 mM KH2PO4 (pH 7.4), 4%
sucrose, 0.50 mg/ml DAB (diaminobenzidine), 200 mg/ml
catalase and 0.15 mg/ml cow heart cytochrome c] was added
to each section, and slides were incubated in a moist chamber
for 20 min at 37˚C in the dark. The reaction was terminated
by washing the slides three times in 100 mM KH2PO4 (pH 7.4).
Slides were rinsed once in distilled water, air-dried for 3 h and
mounted with Permount. For semi-quantitative assessment of
the intensity of the CcO histochemical reaction, images were
captured with a SPOT Flex Camera (Diagnostic Instruments)
attached to a Leitz Laborlux 12 Microscope equipped with a
256objective. The white balance was adjusted for the slide
before taking images so the same background was used for
both Plp1tg and controls. Images taken from the dorsal
medial striatum, ventral lateral striatum, corpus callosum,
hippocampus and cortex of both Plp1tg and control sections,
both of which were on the same slide, were taken at 24 bits
per pixel RGB. Images were opened in Adobe Photoshop,
inverted and three histograms including an area of 3006300
pixels were obtained, averaged and compared between Plp1tg
and controls. Brains from six Plp1tg and six controls were
analysed. Statistical analysis (ANOVA) was used to determine
differences between groups. The average of Plp1tg was
reported as the percentage increase over the average
histogram of control sections.
Mitochondrial membrane potential (DYm)
We first measured DYm with the probe JC-1 (Invitrogen) in
transfected COS7 cells and secondly ex vivo in brain slices.
Cells grown on 12 mm coverslips, were transiently transfected
using Lipofectamine
TM (Invitrogen) with a N-terminal EGFP
(enhanced green fluorescent protein)-linked full-length PLP
cDNA when cells were approx. 70% confluent (see below).
Cell were also transfected with P0–EGFP, Na
+ channel b-
subunit–EGFP, PMP22–EGFP and LacZ–EGFP. At 8 or 24 h
after transfection, JC-1 was added to the cells (10 mg/ml) in
DMEM (Dulbecco’s modified Eagle’s medium; Gibco) supple-
mented with 10% (v/v) FBS (fetal bovine serum; Gibco) with
antibiotics. Cells were incubated at 37˚C with 5% CO2 for 15
min. Medium was replaced with fresh medium, and cells were
incubated for 15 min, washed three times in PBS, mounted in
PBS and immediately imaged. Images were obtained on a
Leica DMIRB Microscope equipped with a 206objective using
a SPOT RT Slider camera, and images were compiled in Adobe
Photoshop. The green monomeric form of JC-1 is excited at
485 nm and emits at 535 nm; the red aggregate form is
excited at 550 nm and emits at 600 nm. Red and green can be
imaged either simultaneously or individually using the
appropriate filters. However, excitation with a FITC filter for
green JC-1 also excites EGFP, making the two difficult to
distinguish.
For in vivo measurements, unfixed brains were immediately
removed, 100 mm sections were cut on a Vibratome in PBS at
37˚C, collected in PBS at 37˚C, first incubated in DMEM for 5
min at 37˚Cw i t h5 %C O 2, next in DMEM containing 3.33 mg/ml
JC-1 for 30 min, and lastly in DMEM without JC-1 for 20 min,
rinsedtwice inPBSand mounted onglass slideswith a coverslip
in PBS. Slices were photographed within several minutes of
rinsing. Images were captured as described above.
Cellular fractionation and Western blot analysis
Mitochondrial/cytosolic and nuclear/cytosolic fractionation
kits were used following the manufacturer’s instructions
(Biovision). To confirm the purity of the mitochondrial
fractions, Western blots were probed with markers for Golgi
(Golgin 97; Molecular Probes), ER (anti-KDEL; StressGen),
lysosomes [anti-LAMP2 (lysosome-associated membrane pro-
tein 2); ABR], mitochondria (anti-CcO; Molecular Probes)
crude plasma membrane fractions (anti-NG2; Chemicon),
pan-Na
+ channel and b-actin (Sigma), and an anti-PLP
antibody directed against the PLP-specific domain generated
for the Skoff laboratory by ABR. Blots were lightly stripped
and reprobed as many as six times. For antigens with higher
molecular masses (above 180 kDa), the same homogenates
were used, but run on an 8% gel rather than our standard
4–12% gel. Fractions of 100 mg were loaded into each lane,
except for brain homogenates when 20 mg was loaded. Each
gel was transferred on to a PVDF membrane, membranes were
blocked with 8% (w/v) non-fat powdered milk, incubated
in antibody overnight, washed, incubated with secondary
antibody, washed and detected using the ChemiLucent
Detection System (Chemicon). In a separate experiment,
cytosolic and mitochondrial fractions were probed for MBP
(myelin basic protein; Sternberger Monoclonals) and PLP/
DM20 against the C-terminus (generated for the Skoff
laboratory by ABR). A 100 mg aliquot of cytosolic and
mitochondrial fractions along with 25 mg of whole brain
homogenate were run on 4–12% gels and transferred on to a
PVDF membrane. Membranes were processed as described
above, and MBP was detected using the ChemiLucent
Detection System (Chemicon), stripped and reprobed for
C-terminal PLP and DM20, and again for b-actin.
PLP plasmid construction
Plasmid clone 68 of pDM100 (pDM100.68) contained a full-
length cDNA for mouse Plp1 (kindly provided by Professor AT
Campagnoni, University of California at Los Angeles, Los
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167Angeles, CA, U.S.A.). Full-length cDNA of mouse Plp1 was
amplified by PCR and cloned into the pEGFP-N1 and pAcGFP-
C1 vectors (Clontech) at the EcoRI/BamHI site to produce two
different constructs. The constructs were N-terminal PLP–
EGFP and C-terminal pAcGFP–PLP. The resulting plasmid
constructs were propagated by standard procedures and
purified using a Maxi-Prep Plasmid Kit (Qiagen). Orientation
of the cDNA insert was confirmed by restriction mapping and
DNA sequencing (Applied Biosystems). Transfection of these
constructs into COS7 cells and positive immunostaining with
PLP-specific antibodies, including live staining with the O10
antibody (Jung et al., 1996), confirmed translation and
correct insertion of PLP into the plasma membrane. Then,
210 and 220 N-terminal amino acid deletion mutants were
generated by touch-up PCR amplification of PLP cDNA-
containing plasmid pDM100.68. Primers with N-terminal 10
and 20 amino acid deletions were designed with the N-
terminal methionine residue intact, and the product was sub-
cloned into EGFP-N1 at the EcoRI and BamHI restriction sites.
Mutant clones were confirmed by sequencing. Cycling
conditions were 95˚C for 1 min, 95˚C for 50 s, 48˚C for 1
min, 68˚C for 1 min for 3 cycles and 58˚C for 25 cycles.
In vitro co-localization of PLP to mitochondria
COS7 cells were cultured in DMEM supplemented with 10%
(v/v) FBS containing antibiotics. All transient transfections
were performed using this non-glial cell line and were
performed when the cells were 70% confluent using
Lipofectamine
TM 2000 with approx. 500 ng–1 mg of cDNA
for approx. 4 h. The constructs used were all driven by CMV
(cytomegalovirus): N-terminal EGFP full-length PLP fusion
protein, EGFP, P0 (courtesy of Dr J. Kamholz, Wayne State
University, Detroit, MI, U.S.A.), Na
+ channel subunit 1
(courtesy of Dr L. Isom, University of Michigan, MI, U.S.A.),
PMP22 (courtesy of Dr G. Snipes, Baylor University, U.S.A.)
and CK (creatine kinase)–YFP (yellow fluorescent protein).
Cells were rinsed and grown for an additional 24 or 48 h.
Mitochondria were live-stained with Mitotracker Red 580
(Molecular Probes). Cells were imaged on a Zeiss Apotome
Fluorescent Microscope (Axio Vision 4.7.Ink), images were
deconvolved using Huygens Essential Software (Scientific
Volume Imaging B.V.) and compiled in Adobe Photoshop. In
the co-transfection studies COS7 cells were co-transfected
with wild-type PLP–EGFP and wild-type CK–YFP, allowed to
grow for 24–48 h, live-stained with Mitotracker Red 580,
fixed and analysed by confocal fluorescent microscopy using
the Leica TCS SP5 microscope (LASAF8.1.1), and images were
processed as described above.
Electron microscopy
We quantified the area occupied by mitochondria in Olgs of
Plp1tg, jp and their appropriate controls. Mice were perfused
intracardially with 4% (w/v) formaldehyde prepared from
paraformaldehyde or with the addition of 0.5% glutaralde-
hyde (Electron Microscopy Sciences). Corpora callosa and
striata from 35–45 day old Plp1tg (n53) and age-matched
controls (n52), and 15–17 day post-natal jp mice (n52) were
thin-sectioned. Beginning in the centre of a grid and working
outwards, all cells with moderate-to-dense cytoplasm were
photographed until approx. 50 cells were photographed.
After development, cells were classified as Olgs, microglia,
astrocytes or unclassifiable because of too little cytoplasm.
Approx. 25 Olgs per mouse were digitized for quantification.
The perimeter of the plasma membrane and nucleus was
outlined with ImageJ (National Institutes of Health), and the
cytoplasmic area was obtained for each cell by subtracting
the nuclear from total cellular area. For these same cells, the
number of mitochondria was calculated, their areas were
outlined and summed. The numbers and area of the
mitochondria were calculated as a percentage of the
cytoplasmic area.
Post-embedding immunogold electron
microscopy
For immunogold electron microscopy, 30–50 day old Plp1tg
mice were perfused with 4% (w/v) paraformaldehyde and
0.5% glutaraldehyde, brains were dissected and 1 mm63m m
blocks were embedded in LR White (London Resin Company)
following the manufacturer’s protocol. Ultra-thin sections
were cut and mounted on 200 mesh nickel grids. A PLP
antibody to the C-terminus diluted 1:500 in PBS was applied
overnight, grids were rinsed, a secondary goat anti-rabbit
antibody conjugated to 12 nm gold particles (Jackson
ImmunoResearch Laboratories) was applied for 2 h, and
sections were rinsed, air-dried and lightly stained with uranyl
acetate and lead citrate. Thin sections were systematically
scanned for Olg perikarya, photographed, and then astrocytes
and neurons in closest proximity to the Olgs were photo-
graphed. The striatum and corpora callosa were imaged on a
JEOL 1010 electron microscope, negatives were scanned into
Adobe Photoshop and printed for analyses. Both the number
of mitochondria and the number of gold particles overlying
mitochondria were counted in different cell types (Olgs,
astrocytes, neurons and their processes). The assumption is
that PLP is not present in mitochondria of cells; therefore,
any increase in the percentage of mitochondria with gold
particles in a certain type of cell indicates specific
localization. The percentage of mitochondria overlain with
gold particles was counted for each cell type in Plp1tg.
RESULTS
The levels of ATP in whole brain homogenates of Plp1tgs and
jp mice were compared with their appropriate controls
(Figure 1). Plp1tgs were 30–35 days old; their phenotype was
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genotype was confirmed by the presence of a transgene
and/or quantitative PCR of the Plp1 gene. Because jp male
mice die between 19 and 22 days, we studied them and their
age-matched controls at 17–19 days. Both sets of mice were
starved for 5–6 h to provide a well-defined metabolic state
for controlled mitochondrial studies (Lee et al., 2005).
Strikingly, Plp1tg mice have a 50% reduction in ATP levels,
whereas jp mice have normal levels. The ATP reduction in
Plp1tgs demonstrates a severely compromised energetic state,
suggesting major mitochondrial dysfunction. Overnight
starvation, which has no apparent effect on wild-type mice,
often resulted in death of Plp1tg mice, indicating not only
that these animals have a severely compromised energy
homoeostasis, but also that food must constantly be provided
to compensate for their acute energy deficit.
To determine whether the respiratory chain has intrinsic
deficits, we examined a key mitochondrial enzyme, CcO. CcO
is the terminal enzyme of the mitochondrial respiratory chain
(complex IV) and consumes more than 90% of cellular
oxygen. Overall mitochondrial respiration is tightly coupled
to CcO, and CcO is the proposed pacemaker of oxidative
metabolism in intact cells (Villani et al., 1998; Villani and
Attardi, 2000). In order to determine the range of activities in
which CcO operates, allosteric regulation through ATP (an
allosteric inhibitor that operates under conditions of
sufficient cellular energy) and ADP (an allosteric activator
that operates under conditions when ATP is utilized and
converted into ADP) has to be considered and analysed
(Hu ¨ttemann et al., 2007). We measured CcO activity of
Plp1tg, jp and control mice in the presence of 5 mM ATP and
an ATP-regenerating system or 5 mM ADP. Ex vivo CcO
activities are similar in Plp1tg and jp mice when compared
with their controls (Figure 2). This finding suggests that
oxidative phosphorylation is not intrinsically altered in
either mutant. This ex vivo result does not mean that the
mitochondrial defect is not detectable in brain homogenates
owing to the fact that Olgs represent only a minor fraction of
brain cells. In vivo CcO activity should still be increased
because its activity and oxygen consumption are allosterically
regulated through the ratio of ATP (inhibitor) and ADP
(activator). A 50% reduction in ATP and a concomitant
increase in ADP should lead to full allosteric activation,
assuming that the total adenine nucleotide concentration is
not dramatically changed in the Plp1tg animals. The resulting
increased aerobic activity may explain increased substrate
(food) demand and thus the striking effects on the overnight
starved Plp1tg mice. Figure 1 ATP levels (percentage relative to the control; 100% is
equivalent to 43 mM ATP/mg of solubilized protein) were measured with
the bioluminescence assay (Roche) in 30–35 day old Plp1tg mice, age-
and strain-matched controls, 17–19 day old jp/Ta mice, and age-matched
littermate controls (+/+)
All mice were starved for 5–6 h. The S.E.M. is based on three separate experi-
ments. P,0.0035 for Plp1tg compared with control mice, P.0.05 for jp/Ta
compared with +/+ controls (as measured using a paired Student’s t test).
Figure 2 CcO activities of mice starved for 5–6 h
CcO activity measurements used the polarographic method in the presence of
5 mM ATP or ADP, by increasing the amount of substrate cytochrome c.( A)
Comparison of CcO activities of wild-type (WT, n53; squares) and Plp1tg
mice (n53; triangles) shows no significant difference in CcO activities in the
presence of ATP (open symbols) or ADP (closed symbols). (B) CcO activities of
jp mice (n55; circles) is indistinguishable from wild-type animals (WT, n55;
squares) in the presence of ATP (open symbols) or ADP (closed symbols).
Turnover is the consumed oxygen (mM/min per mg of total protein).
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169CcO histochemistry
CcO activity is directly measurable on brain sections using a
histochemical technique (Wong-Riley, 1979). This method
assesses CcO function in a more physiological context since
the cellular environment is present and mostly intact.
Densitometric sampling of CcO reaction product in white
and grey matter of mice starved for 5–6 h revealed an
average increase of 10% throughout the cerebrum of Plp1tg
mice (Table 1). Although the increase is greatest in white
matter, the grey matter also shows increases, especially the
hippocampus. The smaller than expected changes in CcO
histochemical reactivity are in line with other studies that
show 10–30% increases in reactivity in diseases with
oxidative metabolic disorders (e.g. Wong-Riley et al., 1997).
The modest changes found with this technique may also be
due to the methodology that dilutes cellular components,
including ATP and ADP (Hu ¨ttemann et al., 2008). These values
may underestimate the role of allosteric regulation via the
ATP/ADP ratio.
Histochemical density analysis of grey matter includes
mainly neuronal components, suggesting that neurons are
somehow involved. Interestingly, scattered neurons in Plp1tg
striatum and hippocampus show noticeable increases in
histochemical staining compared with the most intensely
stained neurons in controls. This finding strongly suggests
that metabolism is compromised not only in Olgs, but also in
neurons. Given the 50% reduction in ATP in Plp1tg brains,
oxidative phosphorylation deficiencies in many neural cell
types might be predicted.
Mitochondrial membrane potential (DYm)
DYm is generated by the electron-transport chain complexes
including CcO that pumps protons across the IMM (inner
mitochondrial membrane). Depolarization of DYm is detect-
able with voltage-dependent probes including JC-1. JC-1
exists as a green monomer at low membrane potentials and
accumulates as a red aggregate in mitochondria at around
normal membrane potentials (Lugli et al., 2007). We first
examined DYm in COS7 cells transiently transfected with
a full-length cDNA PLP–EGFP, a full-length cDNA P0–EGFP, a
full-length PMP22–EGFP, a full-length Na
+ channel b-
subunit–EGFP and a LacZ–EGFP. Cells with a normal DYm
exhibit many red punctate ellipsoids in their cytoplasm. With
all constructs, mitochondria in COS7 cells are mainly
perinuclear (Figure 3). At 8–12 h after transfection with
PLP–EGFP, COS7 cells showed low levels of PLP and many red
mitochondria (Figures 3A and 3B). At 24 h after transfection,
COS7 cells exhibited higher levels of PLP and exhibited little
or no red fluorescence in their cytoplasm. Non-transfected
cells on the same coverslip produce red fluorescent
mitochondrial signals indicating that their DYm is normal.
(In the PLP-transfected cells, EGFP and the JC-1 monomer in
mitochondria are excited at nearly the same wavelength,
making it difficult to distinguish between depolarized
Table 1 Histochemical analysis of CcO in cerebrum from control (n56)
and Plp1tg (n56) mice shows a modest increased CcO density in Plp1tg
mice (see the Results section)
Location Percentage increase in Plp1tg over control
Striatum (dorsal medial) 3.67
Striatum (ventral lateral) 8.13
Hippocampus 11.31
Corpus callosum 18.97
Cortex 6.13
Figure 3 JC-1 staining of transiently transfected COS7 cells
(A and E) Cells transfected with wild-type PLP fused to EGFP 8 h afterwards show abundant red-stained mitochondria in cells
expressing moderate levels of PLP. (B and F) At 24 h after transfection with wild-type PLP–EGFP, most transfected cells express high
levels of PLP and have abnormally low DYm, indicated by loss of red-stained mitochondria. Untransfected cells (indicated by arrows)
show abundant red-stained mitochondria, indicative of normal DYm( F). (C and G) Cells transfected with myelin P0 protein (C)o r
PMP22 (G) fused to EGFP show many red-stained mitochondria, even in cells expressing high levels of EGFP. (D and H) Cells
transfected with the b-subunit of the Na
+ channel fused to EGFP (D) or with LacZ–EGFP (H) show many red-stained mitochondria.
Arrows indicate non-transfected cells that have mostly red-stained mitochondria. Scale bar510 mm.
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PMP22, Na
+ channel b-subunit or LacZ constructs
(Figures 3C–3H) show red fluorescent mitochondria, similar
to untransfected cells. The pictures shown in Figure 3
illustrate low- and high-level expression of these plasma
membrane proteins to demonstrate that, even in cells
expressing high levels of proteins, mitochondria stain red.
Therefore overexpression of plasma membrane proteins that
leads to intense GFP fluorescence in the cytoplasm does not
necessarily cause mitochondrial depolarization.
We next compared DYm in brain slices from age-matched
Plp1tg, jp and wild-type mice (Figure 4). Transverse slices of
cerebrum were incubated with JC-1 dye in buffer within 5
min of removing their brains, imaged within 2 min after
rinsing the dye, and images were deconvolved at a later time.
We quantified the ratio between red (mitochondria with
normal DYm) and green (mitochondria with lowered DYm).
Whereas mitochondria with lowered DYm are abundant in
all three preparations and probably reflect oxygen depletion
due to a time lag in imaging, differences between Plp1tg mice
with wild-type and jp mice are dramatic. The ratio of red-to-
green fluorescent signal for 35-day Plp1tg mice is signifi-
cantly reduced 2.5-fold. The ratio of red-to-green fluorescent
signal for 15–17 day jp mice is slightly increased compared
with 15–17 day control mice (Figure 4E). Thus mitochondria
in jp exhibit values similar to controls, even though a larger
percentage of Olgs are dying in jp than in Plp1tg mice
(Cerghet et al., 2001). The hypopolarization of Plp1tg
mitochondria compared with the modest hyperpolarization
of jp mitochondria is relevant to the extensive apoptosis in jp
mice. Hyperpolarized mitochondria lead to production of
increased free radicals, a crucial signal for apoptosis. Since
Plp1tg mitochondria have depolarized membrane potentials,
it is unlikely that they use the same apoptotic pathway as jp
mitochondria.
Mitochondrial abnormalities in vivo
The functional in vivo studies described above suggest that
Olg mitochondria in Plp1tg mice might differ morphologically
from wild-type and jp mice. We quantified the number of
mitochondria per mm
2 of cytoplasm in Plp1tg mice and
compared their numbers with wild-type and jp mice
(Figure 5A). Compared with wild-type mice and jp mice, the
density of mitochondria in Plp1tg Olgs is more than two
times greater than controls. In contrast, the density of
mitochondria in jp Olgs follows the same linear regression
as wild-type Olgs. When the total surface area of Olg
mitochondria is plotted against their cytoplasmic surface
area, Plp1tg Olg mitochondria occupy more than 2-fold
the area of wild-type mice (Figure 5B). Interestingly, the
surface area for Olg mitochondria in wild-type mice hovered
at around 7% with little standard error, suggesting tight
regulation of their numbers. In contrast, Olgs in Plp1tg mice
exhibited extreme morphological variations. In many Olgs,
the cytoplasm is filled with mitochondria (Figure 6). Other
Olgs are morphologically similar to their normal counterparts,
have a normal distribution of mitochondria and are often
associated with thin myelin sheaths, suggesting that they are
newly generated and express low levels of PLP. We have
found increased generation of new glia throughout the
lifespan of these animals, some of which we have confirmed
as microglia (C Tatar and RP Skoff, unpublished data) and
others, possibly Olgs. In addition to the differences in the
density of mitochondria between Plp1tg and control mice,
the mitochondria in Plp1tg mice appear to be structurally
Figure 4 JC-1 staining of brain striata from strain-matched controls (A and B) and Plp1tg (C and D) age-matched mice
Brain slices (100 mm) were stained with JC-1 dye within several minutes of harvesting brains. They were immediately imaged and
images were deconvolved at a later time. Red ellipsoids indicate relatively normal DYm and green ellipsoids represent a decrease in
potential. Controls have few bright green mitochondria. Notice how ‘red-stained’ mitochondria in Plp1tg brains occupy less area than
in controls. Some mitochondria show only red fluorescence (arrows) and others only green fluorescence (arrowheads). (E)
Quantification of the red-to-green ratio. ***P50.003, PLP1tg compared with wild-type PLP control (as measured using a paired
Student’s t test).
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171abnormal. High-magnification pictures of silver–gold sections
of mitochondria show disruptions of the OMM (outer
mitochondrial membrane). Often, rough ER appears fused
to the OMM. Fission of mitochondria and OMM integrity is
associated with apoptosis, loss of DYm and AIF translocation
(Frank et al., 2001).
Association of PLP with mitochondria
We transfected an N-terminal EGFP full-length PLP construct,
a C-terminal GFP full-length PLP construct, an N-terminal
EGFP full-length P0 construct, an N-terminal EGFP full-
length PMP22 construct, an N-terminal EGFP full-length Na
+
channel b-subunit, and EGFP by itself into COS7 cells, and
then labelled mitochondria with Mitotracker Red 580. Cells
were fixed at 12 h intervals up to 48 h after transfection. At
12 h after transfection, COS7 cells expressing GFP–PLP or
PLP–EGFP showed little co-localization of PLP with mito-
chondria (Figure 7A). Between 24 and 48 h after transfection,
extensive co-localization was present throughout the cyto-
plasm (Figures 7B and 7C).
Deconvolution of confocal images exhibits better resolu-
tion and reveals specificity of the co-localization. Both
confocal and deconvolved images show only green fluor-
escence (PLP) in the plasma membrane, indicating that
Mitotracker Red 580 dye does not bleed into the green
fluorescent channel (Figures 7D–7G). Secondly, the green,
orange/yellow and red profiles associated with mitochondria
imaged are often composed of three distinct elements. An all-
green EGFP crescent partially surrounds an all-yellow
structure that sometimes encloses an all-red mitochondrial
component. The green is most likely to be ER that contains
PLP adjacent to mitochondria, the yellow component is most
likely to be the OMM and/or IMM containing PLP, and the red
staining is a portion of a mitochondrium that lacks PLP.
Simultaneous co-transfection of PLP and mtCK (mitochon-
drial creatine kinase), an IMM-associated protein (Speer et al.,
2005), followed by Mitotracker Red 580 staining strongly
suggests the insertion of PLP into the IMM (Figures 7H–7M).
Mitotracker Red 580 and mtCK fluorescence co-localizes, as
predicted, only in the core of the mitochondria, whereas the
outer mitochondrial envelope only stains red (Figures 7H–7J).
PLP co-localizes with Mitotracker Red (Figures 7K and 7L) and
mtCK (Figures 7L and 7M) to produce yellow variants. The co-
localization of PLP to mitochondria is not restricted to COS7
cells, as studies performed with an immortalized Olg cell line
(Ghandour et al., 2002) into which PLP–EGFP is transfected
also shows that PLP co-localizes to mitochondria
(Figures 7N–7P). In contrast with COS7 cells in which most
mitochondria show co-localization with PLP, some mito-
chondria in these Olgs show strong co-localization, whereas
others show no co-localization.
Because the N-terminus of PLP contains motifs for
localization to the IMM (see the Discussion section below),
we made deletions of the first 10 and 20 amino acids that
retain the first amino acid methionine residue. These
constructs show that PLP does not co-localize to mitochon-
dria (Figures 8A–8F). Faint PLP–EGFP staining is detectable at
the plasma membrane, indicating modest transport of these
mutant constructs. Not surprisingly, live immunostaining
with the O10 antibody (Jung et al., 1996) shows that the
mutants are not correctly inserted into the plasma mem-
brane. The specificity of the co-localization of PLP with
mitochondria is confirmed by transfection of other plasma
membrane markers and Mitotracker Red 580 staining. The
myelin plasma membrane protein P0, when transfected into
COS7 cells, does not co-localize with mitochondria
(Figures 9A–9C); PMP22, another Schwann cell plasma
membrane protein, does not co-localize with mitochondria
(Figures 9D–9F). Cells transfected with EGFP alone exhibited
very bright nuclear and cytoplasmic staining, but little co-
localization with mitochondria (results not shown). The
intensity of the EGFP signal in these P0- and PMP22-
transfected COS7 cells is as intense as in the PLP–EGFP or
Figure 5 Mitochondrial abnormalities in Plp1tg mice
(A) The number of mitochondria per mm
2 of Olg cytoplasm is increased more than 2-fold in 35 day old Plp1tg mice compared with
both 35 day old wild-type and jp mice. Each coloured object represents the number of mitochondria contained within the total
cytoplasmic surface area of one Olg. (B) The sum of the mitochondrial area for each Olg was calculated and compared with its total
cytoplasmic area. *P,0.0001, for control compared with Plp1tg and for Plp1tg compared with jp/Ta (measured using a paired
Student’s t test).
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plasma membrane proteins does not necessarily lead to their
co-localization in mitochondria.
Because ER and mitochondria are structurally in close
proximity with each other, it might be argued that the yellow
mitochondrial fluorescence observed with PLP–EGFP or GFP–
PLP constructs and Mitotracker Red is due to fluorescence
bleed through from the ER into mitochondria, or that the two
organelles overlap each other in the z-axis. However, live
Mitotracker Red 580 staining and anti-KDEL (an ER marker)
antibody immunostaining show very little co-localization
(Figures 9G–9I).
We next asked whether PLP co-localized with mitochondria
in vivo using immunoblots and immunogold electron
microscopy. We first prepared whole spinal cord and brain
homogenates, cytosol and mitochondrial fractions from 60
day old wild-type and Plp1tg mice. Immunoblots were
probed with an anti-PLP-specific antibody, stripped and
re-probed with different organelle and plasma membrane
markers. Pure mitochondrial fractions were more easily
purified from spinal cord (Figure 10A) than from brain.
Spinal cord homogenate containing myelin and cytosolic
fractions from wild-type and Plp1tg mice predictably
immunostained for PLP. Approx. 5-fold less homogenate
was loaded compared with the other fractions because the
homogenate contains myelin membranes. The intensity of
the homogenate bands shows the abundance of myelin
proteins in membranes. Mitochondrial fractions from wild-
type mice did not show PLP bands, but they were easily
detectable in Plp1tg mice. Its absence in wild-type mice is not
a loading artefact because actin levels are approximately
equal in both wild-type and Plp1tg mitochondrial fractions.
The specificity of the mitochondrial fractions was shown with
different antibodies. The subunit of CcO, which is coded by
mitochondrial DNA and localized to the mitochondrial
membrane is restricted to mitochondria and absent from
the cytosolic fraction. Contamination of mitochondria with
other cytosolic organelles was eliminated by probing for ER,
Golgi and lysosomal markers. Two plasma membrane markers,
a pan-Na
+ channel and the NG2 antibody that recognizes a
proteoglycan on glial progenitors, were also, predictably,
absent from mitochondrial fractions. Because of the high
molecular mass of the last two antibodies, they were run on a
separate gel, but the same sample was used for both blots. We
also used MBP as a potential control for the purity of the
mitochondrial fractions, but, unfortunately, MBP is drastically
reduced in the transgenics, making this protein a less than
ideal control. In C57 mice, all four MBP isoforms were
abundantly present in homogenates and faintly present in the
cytosolic fraction, whereas only the 21.5 kDa form was
detectable in the Plp1tg cytosolic fraction (Figure 10B).
Drastic reductions of MBP, using immunostaining and
Western blot analysis of total brain homogenates, have been
observed by our and other laboratories (Readhead et al.,
1994; Karim et al., 2007). Although all MBP isoforms were
absent from the Plp1tg mitochondrial fraction (Figure 10B),
PLP and DM20 were detected in the mitochondrial fraction of
Plp1tg mice. Their molecular masses were slightly lower than
in homogenates, but this result is predicted if these proteins
are inserted into mitochondria (see the Discussion section
below). [The molecular mass of PLP in the mitochondrial
fraction in Figure 10(A) appears slightly lower than in the
cytosolic fraction; the obvious difference in molecular masses
in the lower compared with the upper blot may be due to the
length of time the gel was run].
We next investigated whether PLP localizes to mitochon-
dria in Plp1tg mice using pre-and post-embedding immuno-
gold electron microscopy (Figure 11). With pre-embedding
Figure 6 Electron micrographs of an Olg from a 35 day old wild-type
mouse (A) and Olgs from a 35 day old Plp1tg mouse (B and C)
Nuclei are outlined in green and mitochondria in pink. The distribution of
mitochondria and other organelles from the wild-type mouse is typical of
normal Olgs. Although the cytoplasm and nuclei of Plp1tg Olgs are
abnormally electron-dense, their nuclei and plasma membranes are intact,
suggesting that they are still viable.
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173Figure 7 PLP co-localizes with mitochondria in COS7 and immortalized Olg cells
(A–C) Confocal images of COS7 cells transiently transfected with a full-length PLP–EGFP construct and stained with Mitotracker Red.
(A) At 12 h after transfection, most mitochondria in transfected cells stain red, but some show co-localization with PLP (arrow and
inset). Mitochondria in non-transfected cells are all red. (B and C) By 36 h after transfection, co-localization is abundant (arrow
and inset). (D–G) COS7 cells transfected with the GFP–PLP construct for 36 h and live-stained for Mitotracker Red. Single-channel
confocal images (D and E), merged (F) and deconvolved (G) with Huygens Essential Software. PLP-positive plasma membranes and
cytoplasmic organelles (arrowheads) remain green in the merged and deconvolved images; some mitochondria remain red (crossed
arrowhead) in the merged and deconvolved images. Co-localization of PLP and mitochondria (arrows) is abundant in the merged
confocal image. (G) In the deconvolved image, green staining (PLP) surrounds yellow structures (PLP and mitochondria) that often
surrounds a red portion of mitochondria. (H–M) Confocal images of COS7 cells simultaneously transfected with CK–YFP and PLP–
EGFP, and stained with Mitotracker Red 580. (H–J) Mitotracker Red and CK, visualized as canary yellow, co-localize as goldenrod (J).
A thin rim of red, presumably OMM, often surrounds IMM-localized CK (arrows). (K and L) Co-localization of PLP and Mitotracker Red
produces yellow/orange staining. PLP (green) often surrounds the matrix-localized CK staining (yellow; arrows). (M) Co-localization
of PLP (green) and CK (canary yellow) produces a bright yellow staining. Green surrounds CK which has a worm-like configuration,
typical of mitochondrial cristae. (N–P) Confocal pictures of Olg cell line 158N transfected with PLP–EGFP and stained with
Mitotracker Red. Single-channel confocal images (N–O) and merged (P). Scale bar510 mm.
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very limited, approx. 0.25 mm from the surface of the tissue
block, so very few Olgs were located and detected. This
technical problem prevented reliable quantification. Still, the
few Olgs near the tissue surface had abundant gold particles
overlying their mitochondria, whereas mitochondria in other
cells lacked gold particles. With the post-embedding method,
quantification of the number of gold particles overlying Olg
mitochondria showed a severalfold increase compared with
the number of gold particles in mitochondria of astrocytes
and neurons immediately adjacent to the Olgs (percentage
of non-Olg cytosolic structures with gold particles in
mitochondria54; percentage of Olgs with gold particles
in mitochondria516.7). The appropriate control for this study
is to compare numbers of gold particles in mitochondria of
Olgs with adjacent non-Olg cells in the same section. With
the electron microscopy immunogold post-embedding
method, the background (random gold particles) varied
considerably from animal to animal and even, we found,
one side of the grid to the other. This variability is due to
several factors and includes differences in penetration of
the primary antibody into the plastic. This in vivo electron
microscopy data, combined with Western blotting and
transfection experiments, indicates that native PLP co-
localizes with mitochondria.
DISCUSSION
PMD is due to different types of mutations in the Plp1 gene.
Disabilities range from severe motor impairment and
cognitive loss to mild forms in which patients ambulate
and have near normal lifespans (Garbern et al., 1999;
Woodward and Malcolm, 1999; Regis et al., 2005). Future
therapies to treat PMD hinge upon understanding the
molecular and cellular sequence of events that contribute
to behavioural disabilities. Plp1 transgenic mouse line 66
closely mimics PMD patients with duplications and triplica-
tions of the native gene because the mice we use have mainly
duplications, triplications and quadruplications of the native
PLP1 gene. They both have modest increases in proteolipid
protein (Supplementary Figure S2 at http://www.asnneuro.
org/an/001/an001e014.add.htm) (Anderson et al., 1998; Karim
et al., 2007), and exhibit a behavioural phenotype similar to
PMD patients (see the Materials and methods section).
Hallmarks of all Plp1 mutations at the histological level are
varying degrees of dys-, hypo- and de-myelination accom-
panied by Olg death. The failure to form myelin is a direct
consequence of Olg death rather than a feedback mechanism
in which abnormal myelin formation triggers Olg death
(Knapp et al.,1986; Skoff and Knapp, 1990; Skoff, 1995; Yang
and Skoff, 1997). An UPR has been studied in rodents with
missense/nonsense mutations and in Olgs cultured from Plp1
mice with duplications (Southwood et al., 2002; Dhaunchak
and Nave, 2007; Southwood et al., 2007) because an UPR is a
likely candidate to activate cell death pathways (Harding
et al., 2002). An UPR is easily demonstrated in mice with
point mutations such as jp, myelin synthesis deficient and
rumpshaker, but markers of an UPR are, at best, slightly
increased in mice with duplications compared with wild-type
mice (Cerghet et al., 2001). Also, markers of cell death
pathways in these two groups of mutants were different; the
results suggest that the caspase-dependent pathway was
activated in mice with missense mutations and the caspase-
independent pathway was activated in mice with PLP1
duplications (see the Introduction section).
We first studied ATP levels in brains of Plp1tg and jp brains
and found dramatic differences. ATP levels are drastically
Figure 8 (A–F) Confocal pictures of COS7 cells transfected with the first 10 (A–C) or first 20 (D–F) amino acids, exclusive of
methionine, deleted from PLP and stained for Mitotracker Red 580.
Most mitochondria are red and show no co-localization with PLP. However, faint yellow staining is present in some mitochondria.
Truncated PLP is in vesicles that is transported into processes. Scale bar510 mm.
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175reduced in Plp1tg brains, but are normal in jp brains.
Concomitant with ATP reduction in the Plp1tg, DYmi s
severely reduced in both white and grey matter compared
with controls, but not in jp. Predictably, CcO, the terminal
enzyme in oxidative phosphorylation, was modestly increased
in Plp1tg using a histochemical stain. A 50% reduction in ATP,
dramatic decreases in DYm and increases in CcO activity
throughout the white and grey matter make it difficult to
attribute these metabolic differences exclusively to Olgs. The
reason is that Olgs constitute a small volume of brain tissue.
However, energetic coupling between brain cells has been
reported and may explain our observed global energy defects.
Via the so-called astrocyte–neuron lactate shuttle, astrocytes
metabolize glucose to lactate that is secreted and taken up by
neurons to drive aerobic energy production (Kasischke et al.,
2004). Such an energetic coupling could be a more general-
ized mechanism in the brain that involves additional
participants including Olgs. Our DYm measurements sampled
grey matter, as well as white matter, making it highly likely
that neurons were included in these measurements. Large
cells, undoubtedly neurons, show stronger CcO staining in the
striatum of Plp1tgs than in controls. The suggestion that
neurons in Plp1tgs are metabolically abnormal may be
paradoxical considering that the mutation is expressed in
Olgs and not in neurons. However, axonal degeneration in
these same Plp1tg mice has been previously described
(Anderson et al., 1998), indicating that the PLP mutation
affects neuronal function.
Our previous studies and the present study now shed light
upon the neuronal abnormalities. We found global, large
Figure 9 Other myelin proteins do not co-localize with mitochondria
(A–C) COS7 cells transiently transfected with P0–EGFP and stained with Mitotracker Red 580. (A) Mitochondria are tubular or round
structures spread throughout the cytoplasm, but are often aggregated around the nucleus. (B) P0 forms punctate dots throughout
the cytoplasm, large and intensely fluorescent aggregates, and it also outlines the plasma membrane. (C) In the merged image,
mitochondria surrounding the nucleus are not co-labelled with P0 (left-hand arrow); a single mitochondrion near the P0 aggregate
(right-hand arrow) is not co-labelled. (D–F) COS7 cells transiently transfected with PMP22–EGFP and stained with Mitotracker Red
580. PMP22 and P0 do not co-localize with mitochondria in these confocal images except for occasional particles. (G–I) Confocal,
deconvolved images of COS7 cells stained for Mitotracker Red 580, fixed and immunostained for KDEL using a FITC-labelled
secondary antibody. Reticulated pattern characteristic of ER (arrows) and tubular mitochondria (crossed arrows) often abut each
other, but do not co-localize. Close apposition of mitochondria with ER form occasional small dots (arrowheads), but do not show
extensive overlap of PLP with mitochondria. Scale bar510 mm.
MH u ¨ttemann and others
176 E 2009 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commerical use, distribution and reproduction in any medium, provided the original work is properly cited.decreases in pH of Plp1tg brains (Skoff et al., 2004a) and in
stably transfected PLP-expressing cells (Boucher et al., 2002).
When PLP, but not DM20 or control cells, were co-cultured
with dorsal root ganglion neurons, axonal and neuronal
degeneration was striking in these co-culture experiments.
These results are not a tissue culture phenomenon because a
time-lapse proton-flux ex vivo assay revealed that the pH of
buffer derived from Plp1tg brains was significantly decreased
compared with wild-type brains (Skoff et. al., 2004a). These
studies suggest that PLP modulates neural dysfunction/death
by regulation of pH in vitro and in vivo. The level of PLP
regulates the number of Olgs in roughly inverse proportions.
The number of Olgs cultured in the presence of antisense PLP
was increased as much as 7-fold compared with Olgs grown
in control conditions (Yang and Skoff, 1997). The number of
Olgs cultured from Plp1-knockout mice was 2-fold greater
than in wild-type mice (Skoff et al., 2004b). Overexpressing
DM20, an isoform of PLP, knock-in mice (Stecca et al., 2000;
Spo ¨rkel et al., 2002) have near-normal lifespans compared
with shortened lifespans of different overexpressing PLP
mouse lines (Mastronardi et al., 1993; Kagawa et al., 1994;
Readhead et al., 1994; Bradl et al., 1999). Our studies
demonstrate that transfection of native PLP causes PLP to
intercalate into mitochondria, presumably into the IMM.
Mitotracker Red 580 staining combined with transfection of
CK, located in the IMM, shows oval-shaped mitochondria
enclosing a classically shaped IMM/matrix. When PLP is
transfected into the above combination, PLP co-localizes with
CK. Importantly, the co-localization of PLP with mitochondria
is not due to ‘overexpression’ of PLP in COS7 cells and
immortalized Olg cells, such that the protein associates non-
specifically with mitochondria. We have ‘overexpressed’
several different plasma membrane proteins such that their
level of fluorescence was similar and as bright as that for the
PLP-expressing cells, yet these proteins did not co-localize
with mitochondria.
A genome-wide bioinformatics screen and localization
prediction programs did not predict PLP to be a tail-anchored
mitochondrial protein (Nakai and Horton, 1999; Guda et al.,
2004; Kalbfleisch et al., 2007), but this may be due to the
high-stringency parameters applied. The absence of a
canonical mitochondrial-targeting sequence for PLP is not
surprising because, if there were one, PLP would be
exclusively targeted to mitochondria and not to myelin.
Other analyses suggest that PLP is targeted to the OMM
and/or IMM. It is important to discuss this information in
some detail because it lays the theoretical foundation
for our co-localization studies. For tail anchoring into the
OMM a positively charged C-terminus is required (Horie
et al., 2002; Habib et al., 2003) which is present in PLP
(L
267KLMGRGTKF
276). The requirements for insertion into the
OMM are a relatively short C-terminus with a hydrophobic
TMS (transmembrane sequence) that for PLP includes 21 of
28 amino acids in the fourth TMS. All myelin proteins do not
exhibit these C-termini features; P0, for example, which has
nearly 70 amino acids in its C-terminus, is an unlikely
candidate and did not show co-localization to mitochondria.
Similarly, PMP22 and a Na
+ channel b-subunit did not co-
localize with mitochondria in transfection studies, nor was
MBP present in the mitochondrial fractions. Taken together,
these studies indicate that the localization of PLP to
mitochondria is specific to this myelin membrane protein.
For protein localization to the intermembrane space, a
redox-coupled pathway was discovered that involves a redox
chain consisting of Erv1, Mia40 and cytochrome c (Allen
et al., 2005). Proteins imported by this pathway usually
contain a twin Cx3C or Cx9C motif that are oxidized by Mia40
to form disulfide bonds that can trap proteins in the
mitochondrial inter-membrane space. PLP contains single
Cx3C and Cx9C motifs in the N-terminal region, in addition to
a Cx8C sequence located toward the C-terminal part.
Other proteins with disulfide bonds that localize to this
Figure 10 PLP is present in mitochondrial fractions from Plp1tg mice
(A) Immmunoblots of cytosolic and mitochondrial fractions of spinal cord of
60 day old Plp1tg and wild-type C57 mice. Mitochondrial and cytosolic
fractions were prepared using the Biovision Kit. The immunoblot was first
probed with a PLP-specific antibody, stripped and subsequently reprobed for
five other antibodies. The last two antibodies, because of their higher
molecular masses, were run on a gradient gel using the same homogenate.
(B) Immunoblots of whole-brain homogenates, cytosolic and mitochondrial
fractions probed for PLP and MBP from 60 day old C57 and Plp1tg mice. The
antibody to the C-terminus of PLP recognizes both PLP and DM20. PLP and
DM20 molecular masses in the mitochondrial fraction are slightly less than in
whole brain or cytosolic fractions. The antibody to MBP recognizes all four
MBP isoforms present in homogenate and cytosolic fractions in C57 mice, but
are absent from mitochondrial fractions. Actin in the mitochondrial fraction
is always less than in the cytosol [see part (A) above].
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177submitochondrial compartment do not follow this strict rule
(Gabriel et al., 2007; Herrmann and Kohl, 2007). Another
recently described internal signal for protein localization
involves the four amino acid core sequence AVPI together
with a matrix-targeting signal that, if present, is sufficient to
localize proteins to the inter-membrane space (Ozawa et al.,
2007). PLP contains a similar four amino acid motif
(A
171VPV
174) where the terminal isoleucine residue is replaced
by valine, which only differs by the absence of a methyl
group.
Another algorithm which predicts the probability of
membrane protein insertion into the mitochondrial matrix,
shows that PLP has an 18% probability for insertion into the
mitochondrial matrix (Claros and Vincens, 1996). Insertion
into the IMM requires, among other factors, an N-terminal
cleavable pre-sequence which, for PLP, might be between the
19th and 20th amino acid. This N-terminal leader sequence
usually forms an amphipathic helix that contains non-polar
amino acids in addition to positively charged residues,
clustered on one side. Interestingly, our Western blot analysis
shows that the molecular mass of PLP/DM20 in the
mitochondrial fractions is slightly less than in the homog-
enates and cytosolic fractions.
Partial localization or translocation to mitochondria of
plasma membrane and cytoplasmic proteins has been
described, providing a basis for PLP, a plasma membrane,
insertion into mitochondria. The mammalian protein Slit3
localizes to both the cell surface and mitochondria (Little
et al., 2001), and the tyrosine phosphatase Ship2 localizes to
the cytoplasm and mitochondrial intermembrane space (Salvi
et al., 2004). Proteins also translocate to the mitochondria
under certain conditions that include the EGFR (epidermal
growth factor receptor) where it interacts with the CcO
subunit II (Boerner et al., 2004) and Akt after activation of
the pathway (Bijur and Jope, 2003). Localization and insertion
of PLP into the IMM could account for the observed DYm
depolarization and decreased energy levels. In this scenario,
direct interaction with and inhibition of one or more
oxidative phosphorylation complexes, or through generation
of a pore would directly dissipate DYm similar to uncoupling
protein 1 that operates in brown adipose tissue (Brand et al.,
1999). The co-localization of PLP with CK strongly supports
its association with the IMM.
The reduction in ATP levels and decreased DYm predicts, as
we found, an increase in the numbers of mitochondria in
Olgs of Plp1tg mice compared with wild-type and jp mice. An
increase in mitochondria is characteristic of cells with
reduced respiratory capacity, perhaps due to increased fission
and decreased fusion (Detmer and Chan, 2007). The increase
in native Plp1 gene dosage raises the question of whether it
has a role in normal development when mRNA and protein
levels are highly up-regulated. Plp1 mRNA and protein are
expressed at high levels in interdigital webbing of normal
mice, where it co-localizes with apoptotic cells (Skoff et al.,
2004a). In the testes, when PLP/DM20 mRNA is abundant,
apoptotic cells are increased in Plp1tg mice, but decreased
in PLP-null mice, indicating that PLP modulates apoptosis in
many cell types. Whether PLP associates with mitochondria
under these conditions remains to be studied. Most
importantly, our findings of ATP reduction are directly
relevant to PMD patients with duplications. Drugs that
operate through a variety of direct and indirect mechanisms
to prevent reduction of ATP and/or development of gene
therapy to reduce Plp1 expression levels should be feasible
candidates to treat PMD patients.
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